Active mind, body may only do so much against Alzheimer's

February 24, 2016

(HealthDay)—There's plenty of evidence suggesting that people who are active socially, intellectually and physically may stave off Alzheimer's disease. However, a new study shows those efforts may only go so far to keep dementia at bay.

Exercising the mind and body may delay the symptoms of Alzheimer's disease, researchers said, but in most people it does not slow underlying brain changes linked to the disease.

The study was led by Prashanthi Vemuri, of the Mayo Clinic in Rochester, Minn. Her team focused on nearly 400 people aged 70 and older. While none of the participants had dementia, 53 had experienced slight declines in their mental abilities.

Vemuri's team divided the participants into two groups—those with more than 14 years of and those with less.

Each participant underwent brain scans to check for signs of Alzheimer's disease and were also asked about their mental and .

Overall, the participants' jobs, mental and physical activity and education in middle age appeared to have little to no effect on levels of the buildup of amyloid protein plaques in the brain—a factor long associated with Alzheimer's disease. Physical or mental activity levels also appeared to have little impact on brain volume or the brain's sugar metabolism (energy use), the researchers said.

However, the findings were different for a minority of participants—people with an Alzheimer's-linked gene called APOE4. About 20 percent of people carry this gene, Vemuri's team noted.

In that subset, people who had high education levels and who had continued to learn throughout their lives had less amyloid plaque, compared to those with high education levels who did not continue to challenge their mind.

The study was published online Feb. 24 in the journal Neurology.

"Recent studies have shown conflicting results about the value of physical and mental activity related to the risk of developing Alzheimer's disease, and we noticed that levels of education differed in those studies," Vemuri said in a journal news release.

"When we looked specifically at the level of lifetime learning, we found that carriers of the APOE4 gene who had higher education and continued to learn through middle age had fewer amyloid deposition on imaging when compared to those who did not continue with intellectual activity in middle age," she said.

But what about the rather disappointing findings for people without the APOE4 gene? Vemuri believes these people should still exercise and engage in mentally stimulating activities such as reading, playing games and using computers.

"There is substantial evidence that these activities help to delay the onset of memory and thinking problems," she said. "What we don't know is how this process works."

And cause-and-effect is impossible to tease out in this kind of study, Vemuri added. For instance, she said, the relationship might even work in the reverse. "It is possible those who did not continue intellectual activity in did so because they had higher levels of amyloid plaques," she said.

Two Alzheimer's experts agreed that the jury is still out on the subject.

"The conclusions [from this study] are limited and might apply only to those who carry the APOE4 gene," said Dr. Irving Gomolin, chief of geriatric medicine at Winthrop-University Hospital in Mineola, N.Y. "That being said, intellectual stimulation rarely carries any harm and can increase one's general sense of well-being."

Dr. Gisele Wolf-Klein directs geriatric education at Northwell Health in New Hyde Park, N.Y. She agreed that, based on data from the new study, a mentally and physically active lifestyle has only a "minimal" effect on underlying markers of Alzheimer's disease for the average person.

Still, the benefit to people with the APOE4 gene was notable, Wolf-Klein said, and everyone should still be encouraged "to engage in midlife cognitive [intellectual] activities."

Explore further: Keeping mind, body active may not protect against underlying signs of Alzheimer's

More information: The U.S. National Institute on Aging has more on Alzheimer's disease.

Related Stories

Keeping mind, body active may not protect against underlying signs of Alzheimer's

June 10, 2015
While participating in physical activities such as bike riding, dancing, walking and gardening and mentally stimulating activities such as crosswords and reading may reduce the risk of Alzheimer's disease, they may not do ...

Examining lifetime intellectual enrichment and cognitive decline in older patients

June 23, 2014
Higher scores that gauged education (years of school completed) and occupation (based on attributes, complexities of a job), as well as higher levels of mid/late-life cognitive activity (e.g., reading books, participating ...

Can slow walking speed in elderly signal Alzheimer's disease hallmarks?

December 2, 2015
How fast elderly people walk may be related to the amount of amyloid they have built up in their brains, even if they don't yet have symptoms of Alzheimer's disease, according to a study published in the December 2, 2015, ...

Growth factor in brain tied to slower mental decline

January 27, 2016
Older people with higher amounts of a key protein in their brains also had slower decline in their memory and thinking abilities than people with lower amounts of protein from the gene called brain-derived neurotrophic factor, ...

Two Alzheimer's risk genes linked to brain atrophy, promise future blood markers

December 23, 2015
Two genetic variants previously linked to Alzheimer's disease have been more specifically tied to brain atrophy that is characteristic of the disease.

Researchers study connection between cholesterol level and cognitive decline in old age

October 27, 2015
Changes in lifestyle could reduce the risk of developing Alzheimer's disease. That was the conclusion of a study conducted by researchers of Heidelberg University's Network Aging Research (NAR), who examined the data from ...

Recommended for you

Researchers classify Alzheimer's patients in six subgroups

December 5, 2018
Researchers studying Alzheimer's disease have created an approach to classify patients with Alzheimer's disease, a finding that may open the door for personalized treatments.

Neuroscientists pinpoint genes tied to dementia

December 3, 2018
A UCLA-led research team has identified genetic processes involved in the neurodegeneration that occurs in dementia—an important step on the path toward developing therapies that could slow or halt the course of the disease. ...

Detecting signs of neurodegeneration earlier and more accurately

November 30, 2018
Signs of neurodegenerative diseases, appearing years before the emergence of clinical manifestations, can be detected during the examination of medical samples by means of fluorescence microscopy by using new sensitive and ...

Never-before-seen DNA recombination in the brain linked to Alzheimer's disease

November 21, 2018
Scientists from Sanford Burnham Prebys Medical Discovery Institute (SBP) have identified gene recombination in neurons that produces thousands of new gene variants within Alzheimer's disease brains. The study, published today ...

New information on the pathological mechanisms of Alzheimer's disease

November 21, 2018
Researchers at the University of Helsinki have discovered a mechanism by which harmful tau protein aggregates are transmitted between neurons. Alongside amyloid plaques, tau aggregates in the brain are a significant factor ...

DNA vaccine reduces both toxic proteins linked to Alzheimer's

November 20, 2018
A DNA vaccine tested in mice reduces accumulation of both types of toxic proteins associated with Alzheimer's disease, according to research that scientists say may pave the way to a clinical trial.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

not rated yet Feb 26, 2016
"It is noteworthy that THC is a considerably more effective inhibitor of AChE-induced A' deposition than the approved drugs for Alzheimer's disease treatment, donepezil and tacrine, which reduced A' aggregation by only 22% and 7%,respectively, at twice the concentration used in our studies. Therefore, AChE inhibitors such as THC and its analogues may provide an improved therapeutic for Alzheimer's disease, augmenting acetylcholine levels by preventing neurotransmitter degradation and reducing A' aggregation, thereby simultaneously treating both the symptoms and progression of Alzheimer's disease." From "A Molecular Link between the Active Component of Marijuana and Alzheimer's Disease Pathology" at PubMed.

(FYI- AChE= acetylcholinesterase, it speeds the formation of amyloid plaque in your brain; A = amyloid plaque; donepezil and tacrine = Aricept and Cognex)

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.